In a regulatory filing, Tectonic Therapeutic disclosed that its director Timothy Springer bought 50K shares of common stock on September 26th in a total transaction size of $1.44M. Shares of Tectonic Therapeutic are up 4.2% afterhours at $29.79.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECX:
- Tectonic Therapeutic’s TX45 Shows Promise in Phase 1a Trial
- Tectonic Therapeutic participates in a conference call with Piper Sandler
- Tectonic Therapeutic initiated with an Overweight at Wells Fargo
- Tectonic Therapeutic reports Q2 EPS ($4.34), consensus ($1.50)
- Immatics appoints Reicin to board of directors
